---
figid: PMC8300663__antioxidants-10-01022-g005
figtitle: Use of Antioxidants as Potential Co-Adjuvants to Treat Chronic Chagas Disease
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8300663
filename: antioxidants-10-01022-g005.jpg
figlink: /pmc/articles/PMC8300663/figure/antioxidants-10-01022-f005/
number: F5
caption: The ARE-NRF2-KEAP1 signaling pathway. Several factors (phase II inducers)
  can activate the ARE-NRF2-KEAP1 pathway to trigger antioxidant enzymes expression
  (phase II gene products). The pathway starts with the signaling from phase II inducers,
  such as pharmaceuticals, oxidants, antioxidants, electrophile compounds, dietary
  compounds, and intracellular signals which can be sensed by cysteine residues on
  the KEAP1 polypeptide, which release NRF2 to be translocated to the nucleus and
  bind to the ARE sequences in the gene promoter of antioxidant enzyme encoding genes
  to start the transcriptional activation of those genes and mount a cellular antioxidant
  defense response. Mitochondrial ROS/RSN or hydrogen peroxide can also signal on
  KEAP1 to release NRF2 and start the cellular antioxidant defense.
papertitle: The Use of Antioxidants as Potential Co-Adjuvants to Treat Chronic Chagas
  Disease.
reftext: Edio Maldonado, et al. Antioxidants (Basel). 2021 Jul;10(7):1022.
year: '2021'
doi: 10.3390/antiox10071022
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI
keywords: Trypanosoma cruzi | ROS | Chagas | antioxidants | oxidative stress | mitochondrial
  biogenesis
automl_pathway: 0.9364551
figid_alias: PMC8300663__F5
figtype: Figure
redirect_from: /figures/PMC8300663__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8300663__antioxidants-10-01022-g005.html
  '@type': Dataset
  description: The ARE-NRF2-KEAP1 signaling pathway. Several factors (phase II inducers)
    can activate the ARE-NRF2-KEAP1 pathway to trigger antioxidant enzymes expression
    (phase II gene products). The pathway starts with the signaling from phase II
    inducers, such as pharmaceuticals, oxidants, antioxidants, electrophile compounds,
    dietary compounds, and intracellular signals which can be sensed by cysteine residues
    on the KEAP1 polypeptide, which release NRF2 to be translocated to the nucleus
    and bind to the ARE sequences in the gene promoter of antioxidant enzyme encoding
    genes to start the transcriptional activation of those genes and mount a cellular
    antioxidant defense response. Mitochondrial ROS/RSN or hydrogen peroxide can also
    signal on KEAP1 to release NRF2 and start the cellular antioxidant defense.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - srl
  - pgc
  - Polr2A
  - Prim1
  - PolA1
  - PolA2
  - sv
  - Prim2
  - svr
  - CrebB
  - CrebA
  - be
  - Polr2C
  - Polr2B
  - Polr2I
  - Polr2F
  - MKP-4
  - p38b
  - rl
  - p38a
  - p38c
  - lic
  - Nurf-38
  - Ebp
  - AIMP2
  - Hrb87F
  - Sirt1
  - TFAM
  - Amph
  - mit
  - Tom40
  - SNF4Agamma
  - AMPKalpha
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PPARGC1A
  - ERVW-4
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - GRAP2
  - AHSA1
  - POLDIP2
  - SIRT1
  - CAMK4
  - CAMK2G
  - CAMK1
  - CAMK1D
  - CAMK1G
  - CAMK2A
  - CAMK2B
  - CAMK2D
  - APRT
  - MFAP1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
---
